BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10091779)

  • 1. Treatment outcome of patients with brain metastases from malignant germ cell tumors.
    Fosså SD; Bokemeyer C; Gerl A; Culine S; Jones WG; Mead GM; Germa-Luch JR; Pont J; Schmoll HJ; Tjulandin S
    Cancer; 1999 Feb; 85(4):988-97. PubMed ID: 10091779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
    Tscherry G; Jacky E; Jost LM; Stahel RA
    Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of brain metastases in patients with testicular cancer.
    Bokemeyer C; Nowak P; Haupt A; Metzner B; Köhne H; Hartmann JT; Kanz L; Schmoll HJ
    J Clin Oncol; 1997 Apr; 15(4):1449-54. PubMed ID: 9193339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system.
    Allen JC; DaRosso RC; Donahue B; Nirenberg A
    Cancer; 1994 Aug; 74(3):940-4. PubMed ID: 8039122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
    Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
    Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral germ cell tumors in adults. A retrospective study of 19 cases].
    Agranat P; Jedynak P; Epardeau B; Extra JM; Mignot L
    Bull Cancer; 1995 Aug; 82(8):650-9. PubMed ID: 7492821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain metastases and testicular tumors: long-term survival.
    Spears WT; Morphis JG; Lester SG; Williams SD; Einhorn LH
    Int J Radiat Oncol Biol Phys; 1992; 22(1):17-22. PubMed ID: 1370066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
    Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
    Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
    Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
    J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of brain metastasis in nonseminomatous germ cell tumours.
    Mahalati K; Bilen CY; Ozen H; Aki FT; Kendi S
    BJU Int; 1999 Mar; 83(4):457-61. PubMed ID: 10210571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
    J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
    Horwich A; Sleijfer DT; Fosså SD; Kaye SB; Oliver RT; Cullen MH; Mead GM; de Wit R; de Mulder PH; Dearnaley DP; Cook PA; Sylvester RJ; Stenning SP
    J Clin Oncol; 1997 May; 15(5):1844-52. PubMed ID: 9164194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A; Biron P; Philip I; Blay JY; Droz JP
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of brain metastases from germ cell tumors: a single center experience.
    Boyle HJ; Jouanneau E; Droz JP; Fléchon A
    Oncology; 2013; 85(1):21-6. PubMed ID: 23816811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.
    Jensen AW; Laack NN; Buckner JC; Schomberg PJ; Wetmore CJ; Brown PD
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1449-56. PubMed ID: 20045266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group.
    Toner GC; Stockler MR; Boyer MJ; Jones M; Thomson DB; Harvey VJ; Olver IN; Dhillon H; McMullen A; Gebski VJ; Levi JA; Simes RJ
    Lancet; 2001 Mar; 357(9258):739-45. PubMed ID: 11253966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
    Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
    Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
    Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.